IGF1R and neoplasm: Mice with BxPC-3 tumors, orthotopically-implanted in the tail of the pancreas were injected with a single 10 μg dose of DyLight 650-conjugated anti-IGF-1R (clone 24-31) in 150 μl PBS dose via the tail vein 14 days after tumor implantation.